PubTransformer

A site to transform Pubmed publications into these bibliographic reference formats: ADS, BibTeX, EndNote, ISI used by the Web of Knowledge, RIS, MEDLINE, Microsoft's Word 2007 XML.




PMID- 28273022
OWN - NLM
STAT- MEDLINE
DA  - 20170308
DCOM- 20170310
LR  - 20170315
IS  - 1533-4406 (Electronic)
IS  - 0028-4793 (Linking)
VI  - 376
IP  - 10
DP  - 2017 Mar 09
TI  - Pembrolizumab in Non-Small-Cell Lung Cancer.
PG  - 997
LID - 10.1056/NEJMc1615559 [doi]
FAU - Reck, Martin
AU  - Reck M
AD  - German Center of Lung Research, Grosshansdorf, Germany
FAU - Brahmer, Julie R
AU  - Brahmer JR
AD  - Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD
LA  - eng
PT  - Letter
PT  - Comment
PL  - United States
TA  - N Engl J Med
JT  - The New England journal of medicine
JID - 0255562
RN  - 0 (Antibodies, Monoclonal)
SB  - AIM
SB  - IM
CON - N Engl J Med. ;376(10 ):996-7. PMID: 28276230
MH  - *Antibodies, Monoclonal
MH  - *Carcinoma, Non-Small-Cell Lung
MH  - Humans
EDAT- 2017/03/09 06:00
MHDA- 2017/03/11 06:00
CRDT- 2017/03/09 06:00
AID - 10.1056/NEJMc1615559 [doi]
PST - ppublish
SO  - N Engl J Med. 2017 Mar 9;376(10):997. doi: 10.1056/NEJMc1615559.

<?xml version="1.0" encoding="UTF-8"?>
<b:Sources SelectedStyle="" xmlns:b="http://schemas.openxmlformats.org/officeDocument/2006/bibliography"  xmlns="http://schemas.openxmlformats.org/officeDocument/2006/bibliography" >
</b:Sources>